首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   458篇
  免费   37篇
  国内免费   26篇
耳鼻咽喉   1篇
儿科学   6篇
妇产科学   4篇
基础医学   61篇
口腔科学   5篇
临床医学   29篇
内科学   134篇
皮肤病学   13篇
神经病学   7篇
特种医学   3篇
外科学   24篇
综合类   66篇
现状与发展   1篇
预防医学   51篇
药学   67篇
中国医学   29篇
肿瘤学   20篇
  2024年   2篇
  2023年   7篇
  2022年   14篇
  2021年   16篇
  2020年   11篇
  2019年   19篇
  2018年   19篇
  2017年   10篇
  2016年   14篇
  2015年   19篇
  2014年   35篇
  2013年   37篇
  2012年   35篇
  2011年   29篇
  2010年   24篇
  2009年   23篇
  2008年   21篇
  2007年   33篇
  2006年   19篇
  2005年   12篇
  2004年   16篇
  2003年   7篇
  2002年   8篇
  2001年   5篇
  2000年   8篇
  1999年   3篇
  1998年   3篇
  1996年   7篇
  1995年   6篇
  1994年   1篇
  1993年   3篇
  1990年   1篇
  1989年   2篇
  1988年   3篇
  1987年   5篇
  1986年   3篇
  1985年   3篇
  1984年   8篇
  1983年   3篇
  1982年   4篇
  1981年   3篇
  1980年   4篇
  1979年   4篇
  1978年   2篇
  1977年   6篇
  1976年   1篇
  1974年   2篇
  1972年   1篇
排序方式: 共有521条查询结果,搜索用时 0 毫秒
1.
Retinol-binding protein (RBP) is the transport protein that carries retinol in the circulation from the liver to its target tissues. The existence of a cell-surface receptor on the target cells, which mediates the uptake of retinol from RBP, has been known since 1975. Recently, it was identified as an integral transmem-brane protein named STRA6 that is inducible by retinoic acid in certain cancer cells. The receptor was found to be highly specific for RBP, with high affinity, and to be localized in all tissues known to require retinol for their function, particularly the pigment epithelium of the eye.  相似文献   
2.
为筛选大叶紫薇叶中具有降血糖活性的成分,采用3T3-L1细胞葡萄糖消耗模型作为检测手段,对大叶紫薇叶提取物采用HP-20树脂吸附、溶剂萃取、制备薄层分离和制备高效液相分离,导向筛选具有降血糖作用的各分离组分.结果发现,大叶紫薇叶中corosolic acid、熊果酸和总三萜具有降血糖活性.  相似文献   
3.
We examined the changes that occur in the adenosine receptor system during diabetes mellitus. Experimental diabetes mellitus was induced in male Lewis rats with streptozocin (65 mg/kg), and A1 adenosine receptor binding was characterized with [125I]N 6-2-(4-aminophenyl) ethyladenosine. In adipocytes, high-affinity A1 adenosine receptor binding decreased from 1466±228 of protein to 312±123 fmol/mg of protein (p<0.01) following 14 d of untreated diabetes mellitus. Neither the dissociation constant (K d=1.3±0.2 nM) nor the basal level of adenylate cyclase activity (2.8±1.1 pmol cAMP/mg of protein/min) was altered by diabetes mellitus. The dose-response curve for the inhibition of adenylate cyclase byN 6-R-phenylisopropyladenosine (R-PIA), however, did show a rightward shift, indicating that diabetic adipocyte membranes were less sensitive to the effects of adenosine than nondiabetic adipocyte membranes. In contrast, the A1 adenosine receptor-binding characteristics and adenylate cyclase dose-response curve for cerebral cortical tissue were unchanged by diabetes. These findings suggest that diabetes has tissue-specific effects on the A1 adenosine receptor system. Furthermore, the decreased sensitivity to adenosine potentially worsens the hyperlipidemia associated with diabetes mellitus. Such alterations in the adenosine receptor system may play a previously undescribed role in the pathophysiology of diabetes mellitus and may help explain why some organs are severely affected by diabetes, but others are relatively spared. Understanding these alterations in adenosine receptor function may lead tonovel therapies of this common metabolic disease.  相似文献   
4.
In vitro investigations into adipose cell dynamics have revealed intrinsic characteristics of massively obese individuals' cells that could contribute to a relatively intractable expanded fat mass. Morbidly corpulent peoples' preadipocytes replicate to a greater degree than those from lean individuals. Coupled with exaggerated differentiation this enhanced growth would result in a greater number of fat cells which would increase adipose tissue mass. The relative resistance to de-differentiation that adipocytes from the massively obese demonstrate would contribute to stability of an increased number of adipocytes further exacerbating the problem. The increased message of an energy sensing protein, the obese gene product, suggests that the morbidly obese are insensitive to its action. Together these attributes provide a strong argument for a significant genetic role in the pathogenesis of obesity.  相似文献   
5.
王昌兰  高志红  常爱玲  王宝利 《天津医药》2015,43(12):1353-1355
目的探讨miR-320-3p 对脂肪细胞分化的影响。方法分离并培养小鼠骨髓间充质干细胞(MSCs),并对其进行脂肪细胞诱导分化3 d,用qRT-PCR 检测miR-320-3p 在成脂分化过程中的表达水平。在骨髓基质细胞系 ST2 中转染miR-320-3p,对其进行成脂方向诱导分化,用油红O 染色和qRT-PCR 检测miR-320-3p 对ST2 成脂分化的影响。结果MSCs 向脂肪细胞分化过程中miR-320-3p 表达增加(P < 0.01);与转染阴性对照NC mimics 相比,ST2 细胞转染miR-320-3p mimics 后油红O 染色显示脂肪细胞明显增多,脂肪细胞特异性转录因子过氧化物酶体增殖物激活受体γ(PPARγ)、CCAAT 增强子结合蛋白α(C/EBPα)和脂肪细胞脂肪酸结合蛋白4(FABP4)基因表达显著升高,差异有统计学意义(P < 0.05)。结论miR-320-3p 可促进ST2 向脂肪细胞分化。  相似文献   
6.
目的 研究缺氧环境下成熟脂肪细胞体外培养的形态学变化,探讨缺氧环境对成熟脂肪细胞去分化的影响.方法 从成人吸脂术后抽吸物提取脂肪组织来源的干细胞,诱导为成熟脂肪细胞,在缺血缺氧的环境下培养.观察各时间段细胞的形态变化.结果 由脂肪组织来源的干细胞诱导而成的成熟脂肪细胞,在缺氧环境培养数日后,细胞从圆形变为可持续分裂的成纤维细胞状细胞.结论 成熟的脂肪细胞在一定条件下可以去分化为成纤维细胞状细胞.  相似文献   
7.
Increased circulating free fatty acid (FFA) concentrations have been demonstrated to potentially link obesity, insulin resistance and cardiovascular diseases. Astragaloside IV (AS-IV) is a saponin which is widely used in traditional Chinese medicine to treat type 2 diabetes and cardiovascular diseases. The purpose of the present study was to examine the effects of AS-IV on the lipolysis and insulin resistance induced by tumor necrosis factor-alpha (TNFalpha) in cultured 3T3-L1 adipocytes. TNFalpha promotes lipolysis in mammal adipocytes via the mitogen activated protein kinase (MAPK) family resulting in reduced expression/function of perilipin. Application of AS-IV inhibited TNFalpha-induced accelerated lipolysis in a dose-dependent manner, which was compatible with suppressed phosphorylation of ERK1/2 and reversed the downregulation of perilipin. Moreover, TNFalpha induced downregulation of key enzymes in lipogenesis, including LPL, FAS and GPAT, were also attenuated by AS-IV. Further studies showed that AS-IV improved TNFalpha-induced insulin resistance in 3T3-L1 adipocytes. This study provides the first direct evidence of the antilipolytic action of AS-IV in adipocytes, which may allow this agent to decrease the circulating FFA levels, thus increase insulin sensitivity and treat cardiovascular diseases.  相似文献   
8.
Obesity is a multifactorial disease and is associated with an increased risk of developing metabolic syndrome and co-morbidities. Dysregulated expansion of the adipose tissue during obesity induces local tissue hypoxia, altered secretory profile of adipokines, cytokines and chemokines, altered profile of local tissue inflammatory cells leading to the development of low-grade chronic inflammation. Low grade chronic inflammation is considered to be the underlying mechanism that increases the risk of developing obesity associated comorbidities. The glucocorticoid induced protein annexin A1 and its N-terminal peptides are anti-inflammatory mediators involved in resolving inflammation. The aim of the current study was to investigate the role of annexin A1 in obesity and associated inflammation. To achieve this aim, the current study analysed data from two feasibility studies in clinical populations: (1) bariatric surgery patients (Pre- and 3 months post-surgery) and (2) Lipodystrophy patients. Plasma annexin A1 levels were increased at 3-months post-surgery compared to pre-surgery (1.2 ± 0.1 ng/mL, n = 19 vs. 1.6 ± 0.1 ng/mL, n = 9, p = 0.009) and positively correlated with adiponectin (p = 0.009, r = 0.468, n = 25). Plasma annexin A1 levels were decreased in patients with lipodystrophy compared to BMI matched controls (0.2 ± 0.1 ng/mL, n = 9 vs. 0.97 ± 0.1 ng/mL, n = 30, p = 0.008), whereas CRP levels were significantly elevated (3.3 ± 1.0 µg/mL, n = 9 vs. 1.4 ± 0.3 µg/mL, n = 31, p = 0.0074). The roles of annexin A1 were explored using an in vitro cell based model (SGBS cells) mimicking the inflammatory status that is observed in obesity. Acute treatment with the annexin A1 N-terminal peptide, AC2-26 differentially regulated gene expression (including PPARA (2.8 ± 0.7-fold, p = 0.0303, n = 3), ADIPOQ (2.0 ± 0.3-fold, p = 0.0073, n = 3), LEP (0.6 ± 0.2-fold, p = 0.0400, n = 3), NAMPT (0.4 ± 0.1-fold, p = 0.0039, n = 3) and RETN (0.1 ± 0.03-fold, p < 0.0001, n = 3) in mature obesogenic adipocytes indicating that annexin A1 may play a protective role in obesity and inflammation. However, this effect may be overshadowed by the continued increase in systemic inflammation associated with rapid tissue expansion in obesity.  相似文献   
9.
Recently, we have demonstrated a decreased level of iso-branched-chain fatty acids (iso-BCFAs) in patients with excessive weight. However, it is still unclear whether BCFAs may influence lipid metabolism and inflammation in lipogenic tissues. To verify this, human visceral adipocytes were cultured with three different concentrations of selected iso-BCFA (14-methylpentadecanoic acid) and anteiso-BCFA (12-methyltetradecanoic acid), and then the expression of genes associated with lipid metabolism (FASN—fatty acid synthase; SREBP1—sterol regulatory element-binding protein 1; SCD1—stearoyl-CoA desaturase; ELOVL4—fatty acid elongase 4; ELOVL6—fatty acid elongase 6; FADS2—fatty acid desaturase 2; FADS1–fatty acid desaturase 1) and inflammation (COX-2—cyclooxygenase 2; ALOX-15—lipoxygenase 15; IL-6—interleukin 6) were determined. This study demonstrates for the first time that incubation with iso-BCFA decreases the expression of adipocyte genes that are associated with lipid metabolism (except FASN) and inflammation. These findings suggest that changes in the iso-BCFA profile in obese patients may contribute to adipose inflammation and dyslipidemia. Further studies should evaluate whether iso-BCFA supplementation in obese patients would be beneficial.  相似文献   
10.
体外培养的人脂肪间充质干细胞生物学特性的研究   总被引:12,自引:2,他引:10  
目的:了解体外培养的人脂肪间充质干细胞的生物学特性及其体外成脂和成骨的能力.方法:体外培养人脂肪间充质干细胞并传代计数,行成骨和成脂诱导,流式细胞仪检测其细胞增殖周期与表面分子.结果:人脂肪干细胞经过体外培养均一的阳性表达CD44、CD106,而CD49d、CD34、CD45和HLA-DR表达阴性.细胞周期分析表明:G0/G1、S和G 2/M所占比例分别为79.1%、19.7%和1.3%.分离细胞在诱导体系下可以向成骨和成脂方向分化.结论:脂肪间充质干细胞具有特殊的生物学特点,体外能够向成骨和成脂方向分化.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号